1. Home
  2. KBH vs QURE Comparison

KBH vs QURE Comparison

Compare KBH & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Home

KBH

KB Home

HOLD

Current Price

$42.58

Market Cap

2.6B

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

BUY

Current Price

$22.33

Market Cap

3.1B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
KBH
QURE
Founded
1957
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
KBH
QURE
Price
$42.58
$22.33
Analyst Decision
Hold
Strong Buy
Analyst Count
17
13
Target Price
$52.14
★ $61.24
AVG Volume (30 Days)
1.4M
★ 2.5M
Earning Date
09-22-2026
11-09-2026
Dividend Yield
★ 2.31%
N/A
EPS Growth
N/A
★ 29.67
EPS
★ 2.00
N/A
Revenue
★ $4,547,002,000.00
$13,107,000.00
Revenue This Year
N/A
$54.78
Revenue Next Year
$2.20
$356.14
P/E Ratio
$21.65
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$40.92
$8.73
52 Week High
$67.57
$71.50

Technical Indicators

Market Signals
Indicator
KBH
QURE
Relative Strength Index (RSI) 34.09 25.02
Support Level N/A $20.66
Resistance Level $58.83 $25.61
Average True Range (ATR) 1.25 1.26
MACD 0.06 0.22
Stochastic Oscillator 26.33 38.89

Price Performance

Historical Comparison
KBH
QURE

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: